Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Rho GDP-dissociation inhibitor"'
Publikováno v:
Cell Journal, Vol 24, Iss 5, Pp 239-244 (2022)
Objective: Four and a half Lin-11, Isl-1, Mac-3 (LIM) protein 1 (FHL1) is one of the FHL protein family, which is regarded as a tumor suppressor in the multiple malignant tumors. In this study, we aimed to explore the regulatory effects and mechanism
Externí odkaz:
https://doaj.org/article/2d9fb704fd4b44e99c6724ff9d427f10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Worrall, Donovan, Ryan, Joel, Ayoubi, Riham, Fotouhi, Maryam, Reintsch, Wolfgang, Durcan, Thomas M., Brown, Claire M., McPherson, Peter S., Laflamme, Carl
Head-to-head comparison of available commercial antibodies against Rho GDP-dissociation inhibitor 1 (Rho GDI 1) by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ab1bfdb8e020c2cbcae721ec097298
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Oncotarget
// Li Cui 1, 2, 3 , Naseim Elzakra 1, 2 , Shuaimei Xu 4 , Gary Guishan Xiao 5 , Yan Yang 1, 6 , Shen Hu 1, 2 1 UCLA School of Dentistry, Los Angeles, CA 90095, USA 2 UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 900953, USA 3 Department o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02cf5cad3dcebe38c69e4641ab23b09f
https://doi.org/10.18632/oncotarget.15613
https://doi.org/10.18632/oncotarget.15613
Publikováno v:
Molecular Medicine Reports
Rho GDP-dissociation inhibitor β (RhoGDIβ), a regulator of the Rho family of proteins, is expressed abundantly in the hematopoietic cell lineage. During apoptosis of hematopoietic cells, RhoGDIβ is cleaved by caspase‑3 at Asp19 and this cleaved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::474afba92fb8c37e48fb7d0c144dd41a
https://doi.org/10.3892/mmr.2017.6199
https://doi.org/10.3892/mmr.2017.6199
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vladimir Mrljak, Damián Escribano, Silvia Martínez-Subiela, Zeki Yilmaz, David Eckersall, José J. Cerón, Asta Tvarijonaviciute, Anita Horvatić, Elsa Lamy, Nicolas Guillemin, Lorena Franco-Martínez, Meriç Kocatürk
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Comparative Immunology, Microbiology and Infectious Diseases
Universitat Autònoma de Barcelona
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Comparative Immunology, Microbiology and Infectious Diseases
Graphical abstract
Highlights • Saliva proteome showed 190 differentially expressed proteins in dogs with CPV. • Saliva could be a potential source of biomarkers of diagnosis in CPV. • Catalytic activity and binding are modulated in saliva
Highlights • Saliva proteome showed 190 differentially expressed proteins in dogs with CPV. • Saliva could be a potential source of biomarkers of diagnosis in CPV. • Catalytic activity and binding are modulated in saliva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de7e2ed6ad1d48a6f9ddc89f36987616
https://ddd.uab.cat/record/228065
https://ddd.uab.cat/record/228065
Publikováno v:
The Prostate. 73:1614-1622
INTRODUCTION Treatment of primary prostate cancer (CaP) is the withdrawal of androgens. However, CaP eventually progresses to grow in a castration-resistant state due to aberrant activation of androgen receptor (AR). Understanding the mechanisms lead
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19f9e16e91d125cd78b33a720e677f7f
https://doi.org/10.1002/pros.22615
https://doi.org/10.1002/pros.22615
Autor:
Naoto Takahashi, Katsuhiko Yanaga, Shuichi Fujioka, Atsuo Shida, Norio Mitsumori, Nobuo Omura, Tomoyoshi Okamoto, Hiroaki Aoki
Publikováno v:
Oncology Letters
Small GTPase proteins, including RhoA, RhoB, RhoC, Rac1 and cdc42, are molecules that have significant roles in linking cell shape and cell cycle progression in cytoskeletal arrangements and mitogenic signaling. Rho GDP dissociation inhibitor 2 (RhoG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1809ea97c95e3191c06d2dceafcc05b5
http://europepmc.org/articles/PMC3789053
http://europepmc.org/articles/PMC3789053